DUBLIN, Feb. 15, 2024 /PRNewswire/ — The “Cardiac Ablation – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.
Global Cardiac Ablation Market to Reach $2.4 Billion by 2030
The global market for Cardiac Ablation estimated at US$1.1 Billion in the year 2022, is projected to reach a revised size of US$2.4 Billion by 2030, growing at a CAGR of 10.6% over the analysis period 2022-2030. Radiofrequency (RF) Ablation, one of the segments analyzed in the report, is projected to record 11.2% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Electrical Ablation segment is estimated at 9.5% CAGR for the next 8-year period.
The U.S. Market is Estimated at $522.7 Million, While China is Forecast to Grow at 15.2% CAGR
The Cardiac Ablation market in the U.S. is estimated at US$522.7 Million in the year 2022. China, the world’s second largest economy, is forecast to reach a projected market size of US$196.5 Million by the year 2030 trailing a CAGR of 15.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.3% and 9.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 9.1% CAGR.
What`s New?
- Special discussions on the global economic climate and market sentiment
- Coverage on global competitiveness and key competitor percentage market shares
- Market presence analysis across multiple geographies – Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and trademarked research platform
- Complimentary updates for one year
- Access to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes
Key Topics Covered:
MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- An Introduction to Cardiac Ablation
- Types of Cardiac Ablation Technologies
- Radiofrequency (RF) Ablation
- Electrical Energy-Based Ablation
- Cryoablation
- Ultrasound Energy-Based Ablation
- Microwave Energy-based Ablation
- Cardiac Ablation Market: Growth Prospects and Outlook
- Emerging Markets Forecast to Post High Growth
- Cardiac Ablation – Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- Impact of Covid-19 and a Looming Global Recession
FOCUS ON SELECT PLAYERS (Total 16 Featured)
- Abbott Laboratories (USA)
- AtriCure, Inc. (USA)
- Biosense Webster Inc. (USA)
- Boston Scientific Corporation (USA)
- CardioFocus, Inc. (USA)
- Kardium, Inc. (Canada)
- Medtronic Plc (Ireland)
- Shanghai MicroPort EP MedTech Co., Ltd. (China)
MARKET TRENDS & DRIVERS
- Rising Prevalence of Cardiovascular Diseases and Related Mortality Rates Fuel Cardiac Surgical Volumes Fuel Growth in the Cardiac Ablation Market
- Leading Causes of Mortality Worldwide: Number of Deaths in Millions & % Share of Deaths by Cause for 2017
- Leading Causes of Mortality for Low-Income and High-Income Countries
- Global Cardiology and Cardiac Surgery Market: Revenues in US$ Billion for the Years 2017, 2019, 2021 and 2023
- Aging Global Population at High Risk of Cardiac Illnesses Present Favorable Outlook for Cardiac Ablation Market
- Expanding Elderly Population Worldwide: Breakdown of Number of People Aged 65+ Years in Million by Geographic Region for the Years 2019 and 2030
- As Cardiovascular Disease Prevalence Increases at a Strong Rate in Developing Economies, Tremendous Potential Exists for Cardiac Ablation Market
- Growing Significance of Cardiac Ablation for Cardiac Rhythm Management
- Rising Incidence of Atrial Fibrillation: An Opportunity for Cardiac Ablation Market
- Incidence of Atrial Fibrillation Per Million Population in United States (in %): 2000-2020
- Ranking of Factors for Incidence of Atrial Fibrillation
- Innovative Technologies Assist in Enhancing AF Ablation Process
- Ablation Found to be Effective for AF Compared to Medications
- Ablation Technology for Supra-venticular Tachycardia
- Shift towards Minimally Invasive Surgeries Fuels Demand for Cardiac Ablation Procedures
- Minimally Invasive Catheter Ablation Continues to Gain Prominence in Cardiac Procedures
- RF Ablation Emerges as a Preferred Treatment Option for Cardiac Arrhythmias
- Cryoablation for Treatment of AF: Minimally Invasive Procedure Favors Adoption
- MRI-Guided Cardiac Ablation Market
- Hybrid Ablation Procedure for Treatment of Atrial Fibrillation: Addressing the Limitations of Traditional Treatments
- Technological Advancements Broaden Adoption of Cardiac Ablation Technology
- Advanced 3D Electrophysiology Mapping and Imaging Systems
- Cryoballoon Ablation Catheters
- Laser Balloon Ablation Catheters
- Contact-Force Technology
For more information about this report visit https://www.researchandmarkets.com/r/5y3y69
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo – https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
